* [[Hypogonadism/ja|性腺機能低下症]]（[[Gonadotropin deficiency/ja|ゴナドトロピン欠乏症]]）
...
9 KB (484 words) - 18:09, 16 February 2024
* [[Hypogonadism]] ([[Gonadotropin deficiency]])
...
7 KB (691 words) - 11:10, 16 February 2024
* [[Hypogonadism]] ([[Gonadotropin deficiency]])
...
7 KB (737 words) - 13:22, 17 February 2024
...クシンドローム]]の両方が[[estrogen/ja|エストロゲン]]と[[adipokine/ja|アディポカイン]]の産生を増加させる。これは[[gonadotropin-releasing hormone/ja|ゴナドトロピン放出ホルモン]]を減少させ、ひいては[[luteinizing hormone/ja|黄体形成
...
19 KB (754 words) - 13:06, 4 March 2024
[[Androgen/ja|アンドロゲン]]、[[antiandrogen/ja|抗アンドロゲン薬]]、[[estrogen|エストロゲン]]、[[gonadotropin/ja|性腺刺激ホルモン]]、[[corticosteroid/ja|副腎皮質ホルモン]]、[[human growth hormone/ja|ヒト成長
...ising hormone/ja|黄体形成ホルモン]]、[[LHRH/ja|LHRH]]、[[gamolenic acid/ja|ガモレン酸]]、[[gonadotropin release inhibitor/ja|ゴナドトロピン放出阻害薬]]、[[progestogen/ja|黄体ホルモン]]、[[dopamine ag
...
58 KB (1,845 words) - 17:09, 5 November 2023
...]s, [[antiandrogen|antiandrogen]]s, [[estrogen|estrogen]]s, [[gonadotropin|gonadotropin]], [[corticosteroid|corticosteroid]]s, [[human growth hormone|human growth
...HRH]], [[gamolenic acid|gamolenic acid]], [[gonadotropin release inhibitor|gonadotropin release inhibitor]], [[progestogen|progestogen]], [[dopamine agonist|dopami
...
52 KB (6,923 words) - 17:09, 5 November 2023
...]] both increase [[estrogen]] and [[adipokine]] production. This reduces [[gonadotropin-releasing hormone]], in turn reducing both [[luteinizing hormone]] and [[fo
...
17 KB (2,349 words) - 22:25, 2 March 2024
...]s, [[antiandrogen|antiandrogen]]s, [[estrogen|estrogen]]s, [[gonadotropin|gonadotropin]], [[corticosteroid|corticosteroid]]s, [[human growth hormone|human growth
...HRH]], [[gamolenic acid|gamolenic acid]], [[gonadotropin release inhibitor|gonadotropin release inhibitor]], [[progestogen|progestogen]], [[dopamine agonist|dopami
...
54 KB (7,245 words) - 17:08, 5 November 2023
...]] both increase [[estrogen]] and [[adipokine]] production. This reduces [[gonadotropin-releasing hormone]], in turn reducing both [[luteinizing hormone]] and [[fo
...
18 KB (2,475 words) - 22:24, 2 March 2024
...のメトホルミン対プラセボ/無治療に関するコクラン（2020年）の最新レビューでは、生児出生率の改善に関する決定的な証拠は見つかっていない。長時間の[[Gonadotropin-releasing hormone agonist/ja|GnRHアゴニスト]]プロトコールでは、生児出生率改善のエビデンスには不確実性があったが、臨
...
53 KB (1,662 words) - 16:42, 12 March 2024
...ホメオスタシスまたは調節プロセス]]の調整に寄与していることが示唆される。インスリンはまた、[[hypothalamus/ja|視床下部]]からの[[gonadotropin-releasing hormone/ja|ゴナドトロピン放出ホルモン]]を刺激する作用もあり、したがって[[fertility/ja|生殖能力]]に有
...
80 KB (2,343 words) - 17:40, 19 March 2024
...S no conclusive evidence of improved live birth rates was found. In long [[Gonadotropin-releasing hormone agonist|GnRH-agonist]] protocols there was uncertainty in
...
42 KB (5,783 words) - 19:35, 11 March 2024
...S no conclusive evidence of improved live birth rates was found. In long [[Gonadotropin-releasing hormone agonist|GnRH-agonist]] protocols there was uncertainty in
...
44 KB (5,999 words) - 19:35, 11 March 2024
...y processes]] in the human body. Insulin also has stimulatory effects on [[gonadotropin-releasing hormone]] from the [[hypothalamus]], thus favoring [[fertility]].
...
64 KB (9,275 words) - 16:39, 18 March 2024
...y processes]] in the human body. Insulin also has stimulatory effects on [[gonadotropin-releasing hormone]] from the [[hypothalamus]], thus favoring [[fertility]].
...
65 KB (9,455 words) - 16:37, 18 March 2024